WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001003721) IMPROVED ASSAYS FOR DETECTING HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/003721    International Application No.:    PCT/US2000/019017
Publication Date: 18.01.2001 International Filing Date: 12.07.2000
Chapter 2 Demand Filed:    09.02.2001    
IPC:
C07K 14/16 (2006.01), G01N 33/569 (2006.01)
Applicants: MERLIN BIOMEDICAL & PHARMACEUTICAL, LTD. [US/US]; 6022 Manorfield Drive, Huntington Beach, CA 92648 (US) (For All Designated States Except US).
CULLEN, Gregory [US/US]; (US) (For US Only)
Inventors: CULLEN, Gregory; (US)
Agent: NATAUPSKY, Steven, J.; Knobbe, Martens, Olson & Bear, LLP, 620 Newport Center Drive, 16th Floor, Newport Beach, CA 92660 (US).
ALTMAN, Daniel, E.; Knobbe, Martens, Olson & Bear, LLP, 16th floor, 620 Newport Center Drive, Newport Beach, CA 92660 (US)
Priority Data:
09/351,717 12.07.1999 US
Title (EN) IMPROVED ASSAYS FOR DETECTING HUMAN IMMUNODEFICIENCY VIRUS INFECTION
(FR) DOSAGES AMELIORES DE DETECTION D'INFECTION AU VIRUS DE L'IMMUNODEFICIENCE HUMAINE
Abstract: front page image
(EN)Disclosed herein are modified HIV antigens and corresponding receptors therefore which may be incorporated into existing anti-HIV antibody assays, advantageously increasing the sensitivity and accuracy of the assays. In one embodiment, HIV antigens are biotinylated, and the corresponding receptor is an avidin molecule.
(FR)L'invention concerne des antigènes du VIH et des récepteurs correspondants qui peuvent être incorporés dans des dosages d'anticorps anti-VIH existants, ce qui augmente de manière avantageuse la sensibilité et l'exactitude des dosages. Dans un mode de réalisation, des antigènes VIH sont biotinylés, et le récepteur correspondant est une molécule d'avidine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)